These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22758630)

  • 1. Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.
    Eiserich JP; Yang J; Morrissey BM; Hammock BD; Cross CE
    Ann N Y Acad Sci; 2012 Jul; 1259(1):1-9. PubMed ID: 22758630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.
    Yang J; Eiserich JP; Cross CE; Morrissey BM; Hammock BD
    Free Radic Biol Med; 2012 Jul; 53(1):160-71. PubMed ID: 22580336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and abnormal bioactive lipids in early cystic fibrosis lung disease.
    Scholte BJ; Horati H; Veltman M; Vreeken RJ; Garratt LW; Tiddens HAWM; Janssens HM; Stick SM;
    J Cyst Fibros; 2019 Nov; 18(6):781-789. PubMed ID: 31031161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Think big - think omics.
    Wevers RA; Blau N
    J Inherit Metab Dis; 2018 May; 41(3):281-283. PubMed ID: 29541953
    [No Abstract]   [Full Text] [Related]  

  • 5. Inflammation in cystic fibrosis: An update.
    Roesch EA; Nichols DP; Chmiel JF
    Pediatr Pulmonol; 2018 Nov; 53(S3):S30-S50. PubMed ID: 29999593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic footprint of the airway bacterial community in cystic fibrosis.
    Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
    Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis.
    Esther CR; Coakley RD; Henderson AG; Zhou YH; Wright FA; Boucher RC
    Chest; 2015 Aug; 148(2):507-515. PubMed ID: 25611918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between the lipid content and the rheological properties of airway secretions in cystic fibrosis.
    Galabert C; Jacquot J; Zahm JM; Puchelle E
    Clin Chim Acta; 1987 Apr; 164(2):139-49. PubMed ID: 3594907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
    Puchelle E; de Bentzmann S; Zahm JM
    Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients.
    Gaggar A; Li Y; Weathington N; Winkler M; Kong M; Jackson P; Blalock JE; Clancy JP
    Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L96-L104. PubMed ID: 17384080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.
    Rhim AD; Stoykova L; Glick MC; Scanlin TF
    Glycoconj J; 2001 Sep; 18(9):649-59. PubMed ID: 12386452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive metabolic profiles between Cystic Fibrosis mutational subclasses and lung function.
    Masood A; Jacob M; Gu X; Abdel Jabar M; Benabdelkamel H; Nizami I; Li L; Dasouki M; Abdel Rahman AM
    Metabolomics; 2021 Jan; 17(1):4. PubMed ID: 33394183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic Fibrosis Rapid Response: Translating Multi-omics Data into Clinically Relevant Information.
    Cobián Güemes AG; Lim YW; Quinn RA; Conrad DJ; Benler S; Maughan H; Edwards R; Brettin T; Cantú VA; Cuevas D; Hamidi R; Dorrestein P; Rohwer F
    mBio; 2019 Apr; 10(2):. PubMed ID: 30992350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.
    Polineni D; Dang H; Gallins PJ; Jones LC; Pace RG; Stonebraker JR; Commander LA; Krenicky JE; Zhou YH; Corvol H; Cutting GR; Drumm ML; Strug LJ; Boyle MP; Durie PR; Chmiel JF; Zou F; Wright FA; O'Neal WK; Knowles MR
    Am J Respir Crit Care Med; 2018 Jan; 197(1):79-93. PubMed ID: 28853905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling the Oxylipin and Endocannabinoid Metabolome by UPLC-ESI-MS/MS in Human Plasma to Monitor Postprandial Inflammation.
    Gouveia-Figueira S; Späth J; Zivkovic AM; Nording ML
    PLoS One; 2015; 10(7):e0132042. PubMed ID: 26186333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polarized release of CXC-chemokines from wild-type and cystic fibrosis murine airway epithelial cells.
    Farberman MM; Ibricevic A; Joseph TD; Akers KT; Garcia-Medina R; Crosby S; Clarke LL; Brody SL; Ferkol TW
    Am J Respir Cell Mol Biol; 2011 Aug; 45(2):221-8. PubMed ID: 20639462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
    Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and markers of airway inflammation in cystic fibrosis.
    De Rose V
    Eur Respir J; 2002 Feb; 19(2):333-40. PubMed ID: 11866015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway.
    Karp CL; Flick LM; Park KW; Softic S; Greer TM; Keledjian R; Yang R; Uddin J; Guggino WB; Atabani SF; Belkaid Y; Xu Y; Whitsett JA; Accurso FJ; Wills-Karp M; Petasis NA
    Nat Immunol; 2004 Apr; 5(4):388-92. PubMed ID: 15034576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction to section II: omics in the biology of cystic fibrosis.
    Balch WE
    Methods Mol Biol; 2011; 742():189-91. PubMed ID: 21547733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.